Products

What will AGI do for Amcinafide?

This classification denotes a therapeutic glucocorticoid with the molecular formula C29H33FO6, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier F0Q1D55E29, chemically known as s! 15,112 but generally known as amcinafide, which bears US NIH Compound Identifier 23747. European Medicines Agency schedules Amcinafide in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05403MIG. The term AMCINAFIDE is an International Non-Proprietary Name. AMCINAFIDE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule amcinafide under HS 29372200 and SITC 54153. As of Q4 2014, AMCINAFIDE remains the US FDA Preferred Term for this commodity. Amcinafide bears US NLM identifiers UMLS ID C2825338 and NCI Concept Code C80807. SMILES: FC12C(C3C(C4(OC(OC4C3)(C)C3CCCCC3)C(=O)CO)(CC1O)C)CCC1=CC(=O)C=CC21C.

How AGI delivers it

Four ways AGI delivers for Amcinafide

  • Headless SaaS for Agents

    Give your tools an agent-consumable surface (API / MCP / SDK) so agents can do the work.

    For Amcinafide, give your tools an agent-consumable surface (API / MCP / SDK) so agents can do the work.

  • Services-as-Software

    Get the professional outcome delivered as software, priced on results, not headcount.

    For Amcinafide, get the professional outcome delivered as software, priced on results, not headcount.

Value flow

How Amcinafide connects

measured by

  • Assay Puritymodel
  • Impurity Contentmodel
  • Loss On Dryingmodel
  • Optical Rotationmodel
  • Specific Optical Rotationmodel